2nd Joint International Scientific Meeting "Diabetes Mellitus: Meet the Expert"

Ohad Cohen

Medical Affairs Director – Diabetes EMEA | Medtronic | Institute of Endocrinology, | Chaim Sheba Medical Center, Tel-Hashomer, Israel 52621
Phone No.: 03-5302802 Fax: 03-5302083 | Home Address: 10 Hakeshet St. Quryat Uno, Israel | Phone No.: 052-6667597 | Born: July 18, 1956, Israel | Family Status: + 2.
A. EDUCATION
1984- M.D. Technion, Israel Institute of Technology , Haifa. Cum Laude
1984 - 1989 Board Certification Internal Medicine Beilinson Medical Center
1989 - 1991 Board Certification In Endocrinology and Metabolism – Beilinson Medical Center
Doctoral Dissertation Stability of various insulin solutions for use in implantable insulin pump devices.(1984)
See More

Nebojša M. Lalić

Nebojša M. Lalić (1958), MD, PhD, FRCP, is currently Professor of Internal Medicine at the Faculty of Medicine, University of Belgrade as well as Director and Head of the Department for Metabolic Disorders, Intensive Treatment and Cell Therapy in Diabetes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia in Belgrade. Professor Lalic graduated in 1982 at Faculty of Medicine in Belgrade where he completed residency in Internal medicine in 1990, as well as his PhD thesis in 1993. In 1991, he was a visiting scientist at the Clinical Research Section and Immunology Section, Joslin Diabetes Center, Boston, USA. The principal interest of Professor Lalic scientific work in diabetology/endocrinology has been concentrated on the relationship between insulin secretion and insulin sensitivity impairments in Type 2 diabetes, their relevance for the pathogenesis of diabetes and its late complications and the possibilities of their therapeutic modulation (especially insulin pump treatment). See More

Solomon Tesfaye

Solomon Tesfaye is a Consultant Physician/Endocrinologist at Sheffield Teaching Hospitals and Honorary Professor of Diabetic Medicine at the University of Sheffield. He is also Visiting Professor at Shanghai Jiao Tong University and Adjunct Professor at Xiangya Hospital Central Southern University, China. His research projects include the epidemiology, risk factors, pathogenesis, central nervous system involvement and treatment of diabetic neuropathy and neuropathic pain. He has published a book, over 180 original articles in diabetic neuropathy including a landmark study in the NEJM. Was awarded the Prestigious Camillo Golgi Prize of the European Diabetes Association in 2014 for major scientific contributions in Diabetic Neuropathy. He also received the Arnold Bloom Award of Diabetes UK in 2017 for innovative and patient-centered diabetes care. See More

Dorothea Siegel-Axel

Academic career: 1985-1990 Studies of pharmacy, University of Tübingen / 1990-1993 Researcher and PhD thesis, Physiology Institute I, University of Tübingen / 1993-2008 Research Group Leader, Medical Clinic III, Department of Cardiology, University Hospital Tübingen / 2003 Habilitation at the Faculty of Medicine, University Hospital Tübingen, and granting the teaching license in "Experimental Medicine" / 2012 ongoing Associate Professor / Profession: 2006 Co-founder and shareholder of the company Corlmmun/AdvanceCOR in Munich / since 2008 Research Group Leader, Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology and Clinical Chemistry, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen and German Center for Diabetes Research (DZD e.V.)

Hans-Peter Hammes

Hans-Peter Hammes is section head of Endocrinology at the 5th Medical Department of the University Medical Center Mannheim, Heidelberg University, Germany. In his research, he focusses on the role of hyperglycemia and reactive metabolites in the pathogenesis of endothelial dysfunction and damage to the retinal neurovascular unit. He received his MD from the Westfalian Wilhelms University in Münster in 1980, and his board certifications in internal medicine in 1991 and in endocrinology&diabetology in 1996. In 2000, he was appointed Professor at Heidelberg University. He is spokesperson of two DFG sponsored internal research training groups and PI in the CRC 1118 „Reactive metabolites“, both located at Heidelberg University. He was awarded several prices including the Camillo Golgi Award of the European Association for the study of diabetes.

Emmanuel Van Obberghen

MD, PhD Emmanuel Van Obberghen is an internationally recognized expert in insulin action and beta cell response, received his MD (1971) and PhD (1975) from the Free University of Brussels, Belgium.1975 to 1980 he was research associate in the Diabetes Branch of the National Institutes of Health, where he was involved in pioneering studies of the insulin receptor and its alterations in disease. 1980 he has been directing one of the premier diabetes research laboratories in Europe in the Medical Faculty of Nice, France. 1995 to 2015, he served as Professor and Chairman of the Dept. of Biochemistry and Molecular Biology at the Medical Faculty, and Chief of Clinical Chemistry of the University Hospitals. He was also Vice-President of Research of the Board of Directors, and President of the Committee of Biomedical Research and Public Health of the University Hospitals
see more

Prof. Martin Heni, MD

Martin Heni is a researcher and physician at the University Hospital Tübingen, Germany. He is head of the Clinical Research Center for Diabetes. Furthermore, he is deputy head of the Division for Prevention and Treatment of Diabetes at the IDM of the Helmholtz Center Munich. His research focuses on brain control of human metabolism, the regulation of insulin sensitivity and secretion as well as the pathogenesis and treatment of type 2 diabetes and its’ complications.
Martin Heni received his MD from the Eberhard-Karls-University Tübingen in 2008. Since 2015 he is board certified for Internal Medicine, Endocrinology and Diabetology. In 2018 he was appointed as Professor at the University of Tübingen. He was awarded with several prices for his research, including the Rising Star Award of the European Foundation for the Study of Diabetes (EASD).

Cora Weigert

Cora Weigert is Professor of Molecular Diabetology at the Medical Clinic in Tübingen and at the Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany. Her research focusses on mechanisms regulating the metabolic adaptation to physical exercise as they are key factors in the prevention of type 2 diabetes. Combining molecular biological and “Omics” technologies (transcriptomics, proteomics, metabolomics, lipidomics) exercise-regulated myokines, hepatokines as well as metabolites are studied in primary human muscle cells, mouse exercise models and human exercise intervention studies.

Fausto Machicao PhD.,MSc.Msc.

1963 Study of Chemistry ETH Zurich Switzerland and Maximilian Ludwig University Munich Germany MLU Munich Germany.1968 Molecular Genetic Maximilian Ludwig University Munich Germany. 1972 PhD. Max Planck Institute of Biochemistry Proceptor Prof A. Butenandt (Nobel laurate). 1984 Head of Biochemical Departament of Research Group Diabetes of the University Munich. 1992 Director Experimental Development Drug Research Nycomed Oslo/Norwey . 2004 Head of Laboratory for Molecular Genetic and Diagnosis at Deparment of Internal Medicine University Tübingen.
Research Interest: Diabetes: Molecular Mechanism and Genetic of type 2 Diabetes.

Andreas Peter">

Andreas Peter

Current position: Head of the Central Laboratory at the University Hospital in Tübingen and the "DZD clinical chemistry laboratory" at the Institute for Diabetes Research and Metabolism (IDM), Tübingen. Academic Education and Positions:1996-2003 Medical School in Würzburg, Sydney, Kathmandu and Zürich / 1999-2000 Research fellowship with Joel F. Habener, Laboratory of Molecular Endocrinology, Massachusetts General Hospital, HHMI, Harvard Medical School, Boston, USA / 2011 Consultant, Laboratory Medicine and Clinical Chemistry, Head of the Central Laboratory at the University Hospital of Tübingen / 2014 MHBA (Master of Health Business Administration) at the University Erlangen-Nürnberg / 2016 Appointed full Professor (W3) at the Medical Faculty of the University of Tübingen.
Research Interests: Hepatic Lipid Metabolism, Role of the Liver in the Pathophysiology of Diabetes, Novel Biomarkers

PD Dr. Konstantinos Kantartzis

Konstantinos Kantartzis received his MSc and MD in endocrinology and metabolism from the University of Athens, Greece, and his Habilitation at the University of Tübingen, Germany. He is consultant in Internal Medicine and member of the Clinical Research Team in the Department of Endocrinology, Diabetology, Nephrology, Vascular Medicine and Clinical Chemistry and in the Paul-Langerhans-Institute for Diabetes Research and Metabolic Diseases, Member of the German Centre for Diabetes Research, at the University of Tübingen, Germany. His research interests include prevention of type 2 diabetes and the impact of adiposity and body fat distribution, in particular fat accumulation in the liver (fatty liver, NAFLD), on the production and action of adipokines and hepatokines, and eventually on insulin sensitivity.

Hans-Ulrich Häring

PROFESSIONAL EXPERIENCE: Present Position: Head of the IVth Medical Department, University of Tübingen Chair of Internal Medicine, Endocrinology, Diabetes, Angiology, Nephrology and Clinical Chemistry 1986-1996: Head of the Clinical Experimental Department, Institute for Diabetes Research and Oberarzt, IIIrd Medical Department of the Schwabing City Hospital 1983 - 1986: IIIrd Medical Department of the Schwabing City Hospital and Institute for Diabetes Research 1982-1983: Post doctoral fellowship at the Joslin Diabetes Research Laboratories, Harvard Medical School, Boston 1977-1981: Institute of Diabetes Research, Munich

Norbert Stefan

Professor Norbert Stefan, MD, PhD, is holder of the Chair and the W3 Heisenberg Professorship for Clinical and Experimental Diabetology, Department of Internal Medicine IV, University Hospital of Tübingen, Germany. He is also Head of the Department of Pathophysiology of Prediabetes at the Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Zentrum München at the University of Tübingen, Germany. Professor Stefan's scientific interest is to understand the pathogenesis of prediabetes and type 2 diabetes and hereby focuses predominantly on the role of NAFLD, hepatokines and body fat distribution in this process.

Hubert Preissl

Hubert Preissl studied Physics and did his PhD at the Max-Planck Institute for biological Cybernetics in Tübingen. Afterwards he led the magnetoencephalography Center at the University of Tübingen and performed clinical and basic science brain imaging studies. Since 2000 he focused on the effect of metabolic signals in particular insulin on brain function. In addition he implemented the first dedicated fetal magnetoencephalographic system in Europe and investigated the development of human brain and autonomic nervous function in human fetuses and its possible alterations by the metabolic status of the mother. He currently holds a Professorship at the University of Tübingen on central nervous function and type 2 diabetes and heads the Metabolic Neuroimaging group at the Institute for diabetes research and metabolic diseases at the University of Tübingen of the Helmholtz Center Munich

Erwin Schleicher

After a post-doctoral fellowship at the Department of Medicinal Chemistry (Purdue University, Indiana, USA) he joined the Department of Clinical Chemistry and Diabetes Research Group at the University Clinic in Munich. In 1991 he became Director of the Diabetes Research Group. From 1996 he served as head and vice head of Clinical Chemistry/Central Laboratory at the University Hospital Tübingen. His major scientific interests are: i) the molecular mechanism of insulin signal transduction and its impairment leading to type 2 diabetes, ii) the pathogenesis of diabetic vascular lesions including the involvement of the AGE-RAGE-axis iii) the search for biomarkers predicting the development of diabetes and its complications

Harald Staiger

Academic career: 1988-1993 Studies of biology, University of Regensburg / 1993-1998 PhD thesis, University of Regensburg /1998-2007 Postdoc, Universities of Regensburg, Aachen, Tübingen / 2007 Postdoctoral thesis, University of Tübingen / 2007-2016 Lecturer, University of Tübingen / 2011 ongoing Scientific coordinator, head of department, Institute for Diabetes Research and Metabolic Diseases Tübingen / 2016 ongoing Associate professor, University of Tübingen
Scientific achievements / 2006-2018 Editorial board member, International Journal of Adipose Tissue, Peer J, PLoS One / 2017 ongoing Editor-in-chief, Experimental and Clinical Endocrinology & Diabetes / 2013 ongoing Research coordination board member, German Center for Diabetes Research

Baptist Gallwitz

Prof. Baptist Gallwitz is deputy head of the department for Endocrinology, Diabetes and Metabolism at the University of Tübingen, Germany and Past President of the German Diabetes Association. Baptist Gallwitz is board certified in Internal Medicine with a further specialisation in Gastroenterology and Endocrinology.
His scientific focus is on the physiology of incretin hormones. He has been awarded a respectable number of awards and prizes including the Werner Creutzfeldt Prize awarded by the DDG for scientific work in the field of incretin hormones. He is also co-editor of the German standard textbook for clinical diabetology.

Ferruh Artunc

University: Oct./94-Dec./01 Medical School, Eberhard-Karls-University in Tübingen/Germany / Doctoral thesis: Nov./97-Oct./99 Start at the Pharmacological and Toxicological Institute of the University Of Tübingen / Nov./98-März/99 Local Scholarship by IZKF Tübingen Profession: Jan./02- Sept./04 Residency at the University Hospital Of Tuebingen, Department Of Internal Medicine III (Cardiology/Nephrology) / Oct./04-Mar ´06 Research Fellow at the Department Of Physiology, University Of Tuebingen / April ´06 - Continued residency at the University Hospital Tuebingen, Department Of Internal Medicine IV (Endocrinology /Nephrology) / Mar ´09 Specialisation in Internal Medicine / Jan ´10 Associate Professor for Internal Medicine / Dec ´10 Subspecialisation Nephrology / Jan ´13 Subspecialisation Hypertensiology / April ´14 Professor for Internal Medicine/Nephrology

HOTEL	ACCOMMODATION TYPE (double rooms)	PRICE PER ROOM/NIGHT In EUR	BOARD	MINIMUM STAY
ELECTRA PALACE www.electrahotels.gr/el/thessaloniki/electra-palace-thessaloniki	PREMIUM ROOM	210	BREAKFAST	2 NIGHTS
	SUPERIOR SEA VIEW	230	BREAKFAST	2 NIGHTS
MEDITERRANEAN PALACE www.mediterranean-palace.gr	CITY VIEW	150	BREAKFAST	2 NIGHTS
MEDITERRANEAN PALACE www.mediterranean-palace.gr	SEAVIEW	170	BREAKFAST	2 NIGHTS
CITY www.cityhotel.gr	INNER VIEW	140	BREAKFAST	2 NIGHTS
CITY www.cityhotel.gr	CITY VIEW	150	BREAKFAST	2 NIGHTS
EGNATIA PALACE www.egnatiapalace.gr/en	CITY VIEW	125	BREAKFAST	2 NIGHTS

16 - 19 Μαΐου 2019